Tharimmune Inc
Tharimmune Inc (THAR) is a micro‑cap biopharmaceutical company focused on developing immune‑modulating therapeutics. With a market capitalisation of roughly $20 million, it is an early‑stage enterprise where product candidates and research outcomes — rather than steady revenues — primarily drive value. Investors should know this stock typically exhibits high volatility, limited liquidity and greater risk than larger, established firms. Progress hinges on clinical results, regulatory reviews and partnerships or financing events that can materially affect the share price. For those tracking Tharimmune, pay attention to company filings, trial updates and cash runway indicators. This summary is educational only and not investment advice: small biotech stocks can offer meaningful upside but also significant downside, so suitability depends on individual risk tolerance and investment horizon. Consider speaking to a qualified financial adviser before taking a position.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Tharimmune's stock, with a target price of $5 indicating strong growth potential.
Financial Health
Tharimmune Inc shows moderate financial performance with reasonable cash flow and book value per share.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Early‑stage catalysts
Progress in trials or regulatory news can rapidly change valuation, though outcomes are uncertain and can go either way.
High volatility profile
Small market cap and limited liquidity mean share prices can swing sharply; position sizing and risk tolerance matter.
Follow key updates
Watch company filings, press releases and trial registries for material developments, while remembering past performance is not indicative of future results.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
